Results for pseudomonas aeruginosa translation from English to Maltese

pseudomonas aeruginosa
pseudomonas aeruginosa

what is pseudomonas aeruginosa
x’inhu pseudomonas aeruginosa

pseudomonas aeruginosa (note 4)
pseudomonas aeruginosa (nota 4)

pseudomonas
s ≤ 0. 5 mg/ l

absence of pseudomonas aeruginosa in 250 ml.
assenza ta' pseudomonas aeruginosa f'250 ml.

absence of pseudomonas aeruginosa in 250 ml;
assenza ta’ pseudomonas aeruginosa f’250 ml.

enterobacteria pseudomonas
enterobacteria

pseudomonas aeruginosa in any 250 ml sample examined.
pseudomanas aeruginosa fi kwalunkwe kampjun ta' 250 ml eżaminat.

pseudomonas aeruginosa* pseudomonas fluorescens serratia marcescens*
pseudomonas aeruginosa * pseudomonas fluorescens serratia marcescens * mikro- organiżmi anaerobiċi peptostreptococcus spp.

it should only be used to treat lung infections caused by pseudomonas aeruginosa.
għandu jintuża biss biex jikkura infezzjonijiet tal-pulmun ikkawżati minn pseudomonas aeruginosa.

aeromonas species acinetobacter species burkholderia cepacia pseudomonas aeruginosa stenotrophomonas maltophilia anaerobes:
l- ispeċi aeromonas l- ispeċi acinetobacter burkholderia cepacia pseudomonas aeruginosa stenotrophomonas maltophilia anerobi:

pathogen e coli enterococci proteus mirabilis pseudomonas aeruginosa staphylococcus intermedius streptococcus ß-haemolyticus g
patoġenu e coli

pseudomonas aeruginosa* pseudomonas fluorescens serratia marcescens* anaerobic micro-organisms peptostreptococcus spp.
pseudomonas aeruginosa * pseudomonas fluorescens serratia marcescens *

acute lower respiratory tract infections caused by pseudomonas aeruginosa in children and adolescents (5-17
infezzjonijiet akuti tal- passaġġ respiratorju t’ isfel ikkawżati minn pseudomonas aeruginosa fit- tfal u fl- adolexxenti (5- 17- il sena) b’ fibrożi ċistika:

tigecycline is vulnerable to chromosomally-encoded multi-drug efflux pumps of proteeae and pseudomonas aeruginosa.
tigecycline hu vulnerabbli għal pompi tal-effluss chromosomally-encoded multidrug ta’ proteeae u pseudomonas aeruginosa.

pseudomonas aeruginosa is a bacterium that frequently infects the lungs of cystic fibrosis patients at some time during their lives.
pseudomonas aeruginosa huwa batterju li spiss tinfetta l-pulmun ta’ pazjenti b’fibrożi ċistika f’xi żmien matul ħajjithom.

vantobra is used in patients with cystic fibrosis aged 6 years and older to treat lung infections caused by bacteria named pseudomonas aeruginosa.
vantobra jintuża f’pazjenti b’fibrożi ċistika b’età minn 6 snin ’il fuq biex jikkura infezzjonijiet fil-pulmun ikkawżati minn batterja msejjħa pseudomonas aeruginosa.

caystonis an antibiotic used to suppress chronic lung infection caused by the bacteria pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis.
cayston hu antibijotiku li jintuża biex irazzan infezzjoni kronika fil-pulmun ikkawżata mill-batterji pseudomonas aeruginosa f’pazjenti li għandhom 6 snin jew iżjed bil-fibrożi ċistika.

pseudomonas aeruginosa, acinetobacter or staphylococci) may require higher ciprofloxacin doses and co-administration with other appropriate antibacterial agents.
il- kura ta ’ infezzjonijiet ikkawżati minn ċertu batterja (e. ż pseudomonas aeruginosa, acinetobacter, jew staphylococci) għandu mnejn tkun tinħtieġ dożi ogħla ta ’ ciprofloxacin u għoti flimkien ma 'sustanza kontra l- batterja xierqa oħra.

colobreathe is used to control persistent lung infections caused by the bacterium pseudomonas aeruginosa in adult patients and children aged 6 years and older with cystic fibrosis.
colobreathe jintuża biex jikkontrolla infezzjonijiet persistenti tal-pulmun ikkawżati mill-batterju pseudomonas aeruginosa f’pazjenti adulti u tfal minn 6 snin u akbar b’fibrożi ċistika.